Prenatal Screening tests in Dubai & UAE

Compare available Prenatal Screening tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

480.00–2,400.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Prenatal Screening test prices

Showing 1–12 of 12 matching tests.

Prenatal Screening diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-102 Acetylcholinesterase (AChE) Amniotic Fluid Test This diagnostic test evaluates amniotic fluid for abnormal Acetylcholinesterase (AChE) enzyme isoform patterns, indicating the presence of open neural tube defects.	Amniotic Fluid	14–21 days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Acetylcholinesterase (AChE) enzyme isoform patterns"] Parameters [] Preparation ["No fasting required", "Disclose all current medications, supplements, and history of bleeding disorders to clinician", "Completed consent form (Form 35) required"] Indications ["Pregnancies between 13 and 24 weeks gestation", "Clinical suspicion of open neural tube defect", "Elevated maternal serum alpha-fetoprotein", "Abnormal ultrasound findings"] Measurement technique Confirm with laboratory Codes LOINC: 24468-2 ICD-10: Q05, Q01, Q00 Clinical summary This diagnostic test evaluates amniotic fluid for abnormal Acetylcholinesterase (AChE) enzyme isoform patterns, indicating the presence of open neural tube defects.
TEST-1632 Double Marker Test This test evaluates the risk of Trisomy 21 and Trisomy 18 by measuring specific biomarkers in maternal serum during the first trimester.	Serum (Peripheral Blood)	2–3 days	480.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Free β-human chorionic gonadotropin (β-hCG)", "Pregnancy-associated plasma protein-A (PAPP-A)"] Parameters [{"name": "Free β-hCG", "reference_range": null}, {"name": "PAPP-A", "reference_range": null}] Preparation ["No fasting is required.", "Adequate hydration is recommended."] Indications ["First-trimester prenatal screening for Trisomy 21 and Trisomy 18", "Risk assessment based on maternal age"] Measurement technique Confirm with laboratory Codes LOINC: 45756-8 ICD-10: Z36.1 Clinical summary This test evaluates the risk of Trisomy 21 and Trisomy 18 by measuring specific biomarkers in maternal serum during the first trimester.
TEST-1264 FMF First Trimester Screening Test This non-invasive prenatal test evaluates the risk of common chromosomal abnormalities using biochemical markers and ultrasound findings.	Maternal Serum (SST Tube) + Ultrasound NT Data	Same-day report once ultrasound data is submitted	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Maternal serum free β-hCG", "Maternal serum PAPP-A", "Nuchal Translucency (NT) via ultrasound", "Crown-Rump Length (CRL) via ultrasound", "Nasal Bone assessment via ultrasound"] Parameters [{"name": "Free β-hCG", "reference_range": null}, {"name": "PAPP-A", "reference_range": null}, {"name": "Nuchal Translucency (NT)", "reference_range": null}, {"name": "Crown-Rump Length (CRL)", "reference_range": "45–84 mm"}, {"name": "Nasal Bone", "reference_range": "Presence/Absence"}] Preparation ["Fasting is not required", "Do not discontinue prescribed medication without consulting your referring physician"] Indications ["Pregnancy between 11 weeks and 13 weeks 6 days gestation", "Risk assessment for Trisomy 21, 18, and 13"] Measurement technique Confirm with laboratory Codes LOINC: 49091-2 ICD-10: Z36.0, Z13.71, Z36.89 Clinical summary This non-invasive prenatal test evaluates the risk of common chromosomal abnormalities using biochemical markers and ultrasound findings.
TEST-2479 Maternal Serum Screen 2 with Reflex to Non-Invasive Prenatal Testing (NIPT) for Trisomy 21 (Down Syndrome) Test This test evaluates the risk of fetal Trisomy 21 (Down syndrome) using maternal serum markers and cell-free fetal DNA.	Maternal peripheral blood (serum for immunoassay, whole blood for cfDNA extraction)	1–2 business days for serum markers; if reflex triggered, NIPT result within 5–7 business days	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pregnancy-associated plasma protein-A (PAPP-A)", "Free beta-human chorionic gonadotropin (free β-hCG)", "Cell-free fetal DNA (cfDNA)"] Parameters [{"name": "PAPP-A", "reference_range": null}, {"name": "Free β-hCG", "reference_range": null}, {"name": "Trisomy 21 cfDNA", "reference_range": null}] Preparation [] Indications ["Pregnant women between 10 and 13 weeks gestation", "Risk assessment for fetal Trisomy 21"] Measurement technique Confirm with laboratory Codes LOINC: 50826-8 ICD-10: Z36.81 Clinical summary This test evaluates the risk of fetal Trisomy 21 (Down syndrome) using maternal serum markers and cell-free fetal DNA.
TEST-2489 Maternal Serum Screen 4 (Quadruple Test) This test evaluates the risk of fetal chromosomal abnormalities (Trisomy 21, Trisomy 18) and open neural tube defects using four maternal serum markers.	Peripheral whole blood (serum/plasma)	Same day (results typically available within 24 hours)	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Alpha-fetoprotein (AFP)", "Human chorionic gonadotropin (hCG)", "Unconjugated estriol (uE3)", "Inhibin A"] Parameters [{"name": "Alpha-fetoprotein (AFP)", "reference_range": null}, {"name": "Human chorionic gonadotropin (hCG)", "reference_range": null}, {"name": "Unconjugated estriol (uE3)", "reference_range": null}, {"name": "Inhibin A", "reference_range": null}] Preparation ["No specific fasting required", "Inform the lab about gestational age, maternal weight, diabetic status, and IVF history"] Indications ["Second-trimester prenatal screening", "Risk assessment for Down syndrome (Trisomy 21)", "Risk assessment for Trisomy 18", "Risk assessment for open neural tube defects"] Measurement technique Confirm with laboratory Codes LOINC: 60514-5 ICD-10: Z36.0 Clinical summary This test evaluates the risk of fetal chromosomal abnormalities (Trisomy 21, Trisomy 18) and open neural tube defects using four maternal serum markers.
TEST-456 NIPT Advanced 23-Chromosome Panel Test This test evaluates cell-free fetal DNA in maternal blood to screen for common chromosomal aneuploidies.	Peripheral whole blood (maternal plasma)	5–7 business days	2,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Cell-free fetal DNA (cfDNA)", "Trisomy 21", "Trisomy 18", "Trisomy 13", "Autosomal aneuploidies", "Sex aneuploidies"] Parameters [] Preparation ["No fasting required"] Indications ["Screening for common fetal aneuploidies", "Singleton pregnancies from 10 weeks gestation"] Measurement technique Confirm with laboratory Codes LOINC: 82106-5 ICD-10: Z13.89 Clinical summary This test evaluates cell-free fetal DNA in maternal blood to screen for common chromosomal aneuploidies.
TEST-1298 NIPT Microdeletion Screening Test This test screens for common fetal microdeletion syndromes using cell-free fetal DNA from maternal blood.	Peripheral whole blood (maternal venous blood)	8–10 working days	2,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Cell-free fetal DNA (cffDNA)", "Microdeletion syndromes (22q11.2, 1p36, Cri-du-Chat, Prader-Willi/Angelman, Wolf-Hirschhorn)"] Parameters [] Preparation ["No specific fasting required", "No medication changes needed"] Indications ["Singleton pregnancies ≥10 weeks gestation", "Screening for specific microdeletion syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 82659-0 ICD-10: Z36.2 Clinical summary This test screens for common fetal microdeletion syndromes using cell-free fetal DNA from maternal blood.
TEST-515 Non-Invasive Prenatal Test (NIPT) for Twins This test screens for common fetal chromosomal abnormalities (trisomy 21, 18, 13) in twin pregnancies using cell-free DNA from maternal blood.	Peripheral Whole Blood (Maternal)	8–10 Working Days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Cell-free fetal DNA (cffDNA)", "Fetal fraction per fetus"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Twin pregnancy", "Screening for common fetal chromosomal abnormalities"] Measurement technique Confirm with laboratory Codes LOINC: 77649-1 ICD-10: Z36.2 Clinical summary This test screens for common fetal chromosomal abnormalities (trisomy 21, 18, 13) in twin pregnancies using cell-free DNA from maternal blood.
TEST-1197 Prenatal Diagnostic Screening by Karyotyping + FISH Test This test provides a definitive analysis of fetal chromosomes to detect aneuploidies and structural abnormalities.	Amniotic fluid or Chorionic Villus Sample (CVS)	15–20 days (preliminary FISH results in 2–3 days)	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal number (aneuploidy)", "Chromosomal structure", "Specific chromosomes 13, 18, 21, X, Y"] Parameters [] Preparation ["Full disclosure of medical history, including bleeding disorders or allergies.", "Patients are advised not to discontinue prescribed medication without consulting their doctor."] Indications ["High-risk pregnancies", "Abnormal ultrasound findings", "Positive maternal serum screening"] Measurement technique Confirm with laboratory Codes LOINC: 47230-4 ICD-10: O35.1 Clinical summary This test provides a definitive analysis of fetal chromosomes to detect aneuploidies and structural abnormalities.
TEST-1107 Prenatal Spinal Muscular Atrophy (SMA) Screening Test This test detects deletions, duplications, and point mutations in the SMN1 gene from invasive prenatal specimens using MLPA.	Amniotic Fluid, Chorionic Villi, or Cord Blood	7–10 working days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SMN1 gene deletions", "SMN1 gene duplications", "SMN1 gene point mutations", "SMN1 copy-number variants"] Parameters [] Preparation [] Indications ["Family history of spinal muscular atrophy", "Known carrier status for both parents", "Previous children affected by SMA"] Measurement technique Confirm with laboratory Codes LOINC: 53773-6 ICD-10: Z13.79 Clinical summary This test detects deletions, duplications, and point mutations in the SMN1 gene from invasive prenatal specimens using MLPA.
TEST-1177 Quadruple Marker Test This test evaluates maternal serum levels of four specific markers to assess the risk of fetal chromosomal abnormalities and neural tube defects.	Maternal Serum	3–4 Days	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Alpha-fetoprotein (AFP)", "Human chorionic gonadotropin (hCG)", "Unconjugated estriol (uE3)", "Inhibin A"] Parameters [{"name": "Alpha-fetoprotein (AFP)", "reference_range": null}, {"name": "Human chorionic gonadotropin (hCG)", "reference_range": null}, {"name": "Unconjugated estriol (uE3)", "reference_range": null}, {"name": "Inhibin A", "reference_range": null}] Preparation [] Indications ["Second-trimester prenatal screening for chromosomal abnormalities (Trisomy 21, Trisomy 18)", "Screening for neural tube defects"] Measurement technique Confirm with laboratory Codes LOINC: 49586-2 ICD-10: Z36.0, O28.5 Clinical summary This test evaluates maternal serum levels of four specific markers to assess the risk of fetal chromosomal abnormalities and neural tube defects.
TEST-1176 Quantitative Fluorescence PCR (QF‑PCR) Panel for Chromosomes 13, 18, 21, and XY Test This diagnostic test rapidly evaluates amniotic fluid, chorionic villi, or cord blood for common aneuploidies involving chromosomes 13, 18, 21, and the XY sex chromosomes.	Amniotic Fluid, Chorionic Villi, or Cord Blood	1 – 2 Business Days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of extra chromosomes 13, 18, 21", "Sex chromosome abnormalities (XY)"] Parameters [] Preparation ["No specific patient preparation required.", "Do not discontinue prescribed pregnancy medications without consulting the physician."] Indications ["High-risk pregnancies", "Advanced maternal age", "Abnormal prenatal screening results", "Family history of chromosomal abnormalities"] Measurement technique Confirm with laboratory Codes LOINC: 82134-2 ICD-10: Z36.0 Clinical summary This diagnostic test rapidly evaluates amniotic fluid, chorionic villi, or cord blood for common aneuploidies involving chromosomes 13, 18, 21, and the XY sex chromosomes.

Category overview

Prenatal Screening: overview

Protecting your growing baby starts with proactive care, and securing early, accurate insights brings unparalleled peace of mind to expectant parents. Integrated within our advanced Biochemistry services, comprehensive Prenatal Screening evaluates vital biochemical and genetic markers during your pregnancy. Utilizing state-of-the-art diagnostic technology, this preventative prenatal testing helps identify potential developmental risks, offering the definitive clarity needed to safely guide tailored maternal medical care. Trusted by families and physicians across the top diagnostic labs in Dubai and the UAE, DNA Labs guarantees strict patient confidentiality, uncompromising diagnostic accuracy, and highly efficient turnaround times. Safeguard your family's future today—book your prenatal screening testing in UAE, coordinate a secure home sample collection, or connect with our specialized maternal health experts.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.